Clinical Trial Update: Atomoxetine and Oxybutynin in Obstructive Sleep Apnea [Phase 1, Phase 2]

View source ↗

Summary

A Brigham and Women's Hospital trial evaluating atomoxetine and oxybutynin for obstructive sleep apnea has completed Phase 1 and Phase 2, with results posted on…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Sleep Apnea

Drugs mentioned

• Atomoxetine (Atomoxetine)
• oxybutynin (oxybutynin)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Obstructive Sleep Apnea (OSA) | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-01-29